The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
The RCVS is now accepting disclosures from veterinary surgeons about any criminal cautions, convictions or adverse findings they may have against them, as part of a voluntary period before the requirement to disclose commences in 2014.
The requirement that veterinary surgeons notify the College about criminal cautions, convictions or adverse findings on registration, and on an annual basis as part of their registration renewal each March, was introduced as part of the Code of Professional Conduct in 2012 (section 5.3, see Notes to Editors). However, the College has allowed a bedding-in period for the Code before enforcing the requirement.
From 2014, new registrants will have to disclose any criminal cautions, convictions or adverse findings that may affect registration (for example, those from university fitness to practise procedures).
Veterinary surgeons already on the Register (including overseas and non-practising categories, as well as UK-practising) will only be required to disclose criminal cautions, convictions or adverse findings that have occurred since April 2006. Fixed-penalty motoring offences are excluded.
The veterinary profession has fallen under the Notifiable Occupations Scheme since April 2006, which means that serious convictions are already passed to the College from the police.
If a veterinary surgeon declares a criminal conviction, this will be initially considered by the Registrar, and, if necessary, referred to the Preliminary Investigation Committee. In some cases, the matter will be referred on to the Disciplinary Committee to decide if the nature of the caution or conviction affects the veterinary surgeon's fitness to practise - in which case the usual sanctions of removal or suspension from the Register could apply.
Eleanor Ferguson, Head of Professional Conduct said: "We hope, through this new requirement, to increase the public's confidence in the veterinary profession, and to safeguard animal health and welfare. The move brings the veterinary profession into line with many others - including registered veterinary nurses, who have made such a disclosure since their Register was introduced, in 2007."
The RCVS has launched a dedicated advice line to assist affected veterinary surgeons, on 07818 113 056, open Monday to Friday, 11am-4pm.
Callers will speak to one of three RCVS solicitors who can advise on the process and the possible outcomes of disclosure. Alternatively, veterinary surgeons can contact disclosure@rcvs.org.uk.
Detailed information regarding the requirement, including examples of the kinds of convictions that may be referred to the Preliminary Investigation Committee, and a disclosure form, can be found on www.rcvs.org.uk/convictions.
The programme includes more than 130 hours of CPD delivered by over 100 speakers from home and abroad, with talks for all members of the practice team.
The UK speakers include Rebecca Geddes on kidney medicine and nursing; Amy Newfield on IV access techniques; Rob White on brachycephalic surgery and acute abdomen surgical techniques; Penny Watson on liver disease; Dick White on the surgical team; Butty Villiers on cytology for vets and nurses; John Chitty on several rabbits, small furries and exotics topics.
BSAVA President, Professor Ian Ramsey, said: “Following months of meticulous planning we are thrilled that the programme is now live
"The sheer range and high quality of our speakers and content, together with our new, more dynamic format takes webinar learning to a new level."
“Delegates will be able to develop their skills and knowledge on topics they see regularly in practice. To make things even easier we will be providing practical resources such as client handouts for delegates to take back to their clinics. This, coupled with many speakers sharing their own notes and practical resources means less note-taking and a quicker and easier way for delegates to share what they have learnt with their colleagues.”
There will be three keynote speakers; Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader. Two other keynote names will be announced shortly.
On the social side the focus is on bringing people together online to share light-hearted entertainment and laughter. Delegates can exercise their taste buds with some wine and whisky appreciation, throw some shapes with a virtual disco, exercise their bodies as well as their minds with yoga and unwind with some restorative meditation practices.
Ian added: “This year’s BSAVA Congress is going to be the most innovative ever and deliver like never before. There is plenty of relevant and engaging CPD for every practice professional, with all the convenience of a virtual event. If you haven’t already taken a look at the programme and registered, I urge you to do so now. With prices starting at just £99 +VAT for members it represents really great value.”
To register now visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
To achieve the accreditation, Dechra’s Digital Learning team’s educational content, processes and services were reviewed and benchmarked against key opinion indicators by an LPI consultant.
Dechra Academy was first established in the UK in 2010 and has since launched in over 20 additional countries across the world.
Last year, over 5,000 veterinary professionals in the UK completed over 9,000 courses and there is currently over 60 hours of free CPD content available across the company’s therapy areas including endocrinology, dermatology, analgesia and anaesthesia, nutrition, equine analgesia and anaesthesia and locomotion.
The company has just launched the first of two courses in its ‘Purffect Partner’ series, which focuses on identifying and treating unintended feline weight loss.
A further four case studies will be added in the coming months.
www.dechra.co.uk/academy.
The Royal College of Veterinary Surgeons has announced that Nick Stace has been appointed its Chief Executive and Secretary, and will take up his post on 3 September 2012.
Mr Stace leaves CHOICE, Australia's equivalent of consumer group Which?, after three and a half years as Chief Executive Officer. At CHOICE, Nick led the modernisation of the organisation, this year taking it to the number one spot as the most trusted media entity in Australia. A long-standing consumer champion, Nick also held the post of Deputy CEO at Which?, he was a director at Consumers' International and former Prime Minister Gordon Brown's Director of Strategic Communications.
RCVS President Jerry Davies said: "I am delighted that Nick Stace will be joining the College. With his impressive track-record, I believe that we have a Chief Executive who will lead the College into a new phase of modernisation and development. I am grateful to the Interview Panel, led by Council member Dr Barry Johnson, for all their hard work in securing this excellent appointment."
Nick Stace said: "It is an enormous privilege to be leading an organisation that seeks to ensure Britain has the best vets in the world. The College has a special place in the lives of every vet in the country, it also has a responsibility to animals and consumers to set high standards and ensure they are met. I look forward to helping the College continue to improve veterinary standards across the country and to lead the College through its next stage of development."
The role of Chief Executive and Secretary is a new one - previously the Registrar led the executive of the College. One of Nick Stace's first tasks will be to assist in recruitment of the Head of Legal Services/Registrar, a new role.
In the Voice of the Profession survey, 52% of nearly 700 veterinary surgeons said it was their biggest concern, more than double the number that said so two years ago. The figure was even higher amongst veterinary surgeons working in companion animal practice, with 66% citing it as a major issue.
The BVA is highlighting these statistics and encouraging veterinary teams to talk to clients about responsible dog breeding and buying during this year's Puppy Awareness Week, which runs till 10th September.
The BVA and the Kennel Club run Canine Health Schemes which screen dogs for inherited conditions including hip and elbow dysplasia, hereditary eye disease, and Chiari-malformation/Syringomyelia. Dog owners and breeders can use the results to make more informed breeding decisions and help improve the health of breeds susceptible to debilitating or life-limiting inherited conditions.
Pre-breeding testing and screening are not just for purebred pedigree dogs - screening is also important for crossbreed dogs, such as Labradoodles and Cockerpoos, which are becoming increasingly popular.
BVA President Gudrun Ravetz said: "With breeding and hereditary defects emerging as the number one animal health and welfare concern for vets, it is more important than ever to screen before breeding dogs. Vets in practice regularly see cases of inherited conditions such as hip dysplasia and eye problems that are debilitating and distressing for dogs.
"The good news is that we have schemes and tests in place that help breeders and owners make sound judgements about responsible breeding. The BVA/KC Canine Health Schemes and Kennel Club DNA testing services are critical tools for breeders. Anyone thinking of breeding from their dog or thinking about buying a puppy should ask their vet about available health schemes and how they can be used to inform their decisions."
During Puppy Awareness Week, BVA is also working with the Animal Welfare Foundation to promote the use of the Puppy Contract, which contains a section for the breeder to fill out about any health screening or DNA results to offer reassurance to owners.
BVA, in partnership with ITN Productions, has developed a 4-minute film on responsible dog breeding and buying that can be played in practice waiting rooms or on social media channels, which also explains the process and benefits of the Canine Health Schemes.
More details about the BVA/KC Canine Health Schemes can be found at: https://www.bva.co.uk/Canine-Health-Schemes/
Photo: By DodosD - Own work, CC BY-SA 3.0, Link
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
References
Davies Veterinary Specialists has announced that it will be launching a new referral service in the heart of London at an event being held at the Institute of Physics at 7:00pm on 15th February.
As part of the preparations, the multi-discipline referral centre has published a very polished video which you can view here.
The launch event includes some free CPD: "Challenges in Urology", together with drinks and nibbles.
The RCVS has announced the results of the 2016 RCVS Council elections.
Current members Christopher Barker (2,838 votes), Amanda Boag (2,689 votes), Kit Sturgess (2,586 votes) and Stephen May (2,452 votes) were returned to four of the six available seats on RCVS Council. Melissa Donald and Lucie Goodwin are joining Council for the first time with 2,532 votes and 2,307 votes respectively.
The re-election of Stephen May means that he will serve as Junior Vice-President of the RCVS for 2016-17.
Voter turnout was down this year at 15.6% (or 4,403) of those eligible to vote, compared to 18.1% last year and the 17.2% average over the past 10 years.
Eleanor Ferguson, RCVS Acting Registrar, said: "I’d like to congratulate all those who were successfully elected, and re-elected, to Council, and thank all those who took part in this year’s elections – whether by standing as a candidate, casting a vote or submitting questions for the candidates to answer."
The successful candidates will take up their positions at RCVS Day – the College’s Annual General Meeting and Awards Day – on Friday 15 July 2016 at the Royal Institute of British Architects.
Each candidate in the elections was invited to produce a short video in which they answered questions put to them by fellow members of the professions and which appeared on the RCVS YouTube channel. The videos provided by the RCVS Council candidates received 1,169 views while those provided by the VN Council candidates received 779 views.
The elections were run on behalf of the College by Electoral Reform Services.
Defra's new measures include:
Eleven additional licences for badger control covering parts of Devon, Wiltshire, Somerset, Dorset and Cheshire. Licences have been granted for supplementary badger control in areas of Gloucestershire and Somerset which have completed their original four-year licences.
The relaunch of the Badger Edge Vaccination Scheme following suspension due to a global shortage of TB vaccine, with groups invited to submit expressions of interest and feedback on the criteria for the scheme.
A new bTB Advisory Service for farmers to provide advice on-farm and by phone or email to farmers in High Risk and Edge Areas on bTB biosecurity and risk-based trading, set to launch this autumn.
Tighter control of Inconclusive Reactors (IRs) in the High Risk and Edge Area, to come into force from 1 November.
British Veterinary Association (BVA) President Gudrun Ravetz said: "Today’s announcement sees 11 new licences issued and, while BVA supports badger culling as part of a comprehensive strategy for tackling bovine TB, we will continue to call on the Government to use the targeted and humane method of cage trapping and shooting only - rather than the current method of controlled shooting.
"As one of the many tools in the toolbox, we welcome the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. The introduction of a TB Advisory Service will provide valuable additional support for farmers, who we’d encourage to continue working with local vets on biosecurity and herd health planning.
"Yet we are concerned that Government policy seems to have moved away from the original, evidence-based proposal of a six-week time limit for badger control within the open season, which enables an intensive, coordinated and effective operation in order to secure optimum disease control benefits.
"In terms of numbers, it is clear that badger population estimates have previously demonstrated considerable uncertainty and imprecision. It is critical that as accurate as possible population estimates, using an evidence-based methodology, are obtained and made openly available.
"We would urge clarity over cull timeframes, numbers and mid-cull review methodology to ensure that the progress made, enabling the application for Officially TB Free status, is not undermined."
Today’s Defra update follows a consultation on licensed badger control conducted at the start of 2017, to which the British Veterinary Association (BVA), British Veterinary Zoological Society (BVZS) and the Association of Government Veterinarians (AGV) submitted a formal, joint response.
Photo: Young Eurasian Badger (Meles Meles), by BadgerHero, CC BY-SA 3.0
The toolkit contains triage forms, a contact directory, emergency action guidelines and a drug glossary, together with dosage rates for its Anti-Tox Range.
Miranda Davis, Territory Manager at TVM said: "The Toxin Toolkit is designed to make it as easy as possible to access advice when veterinary staff are dealing with pet poisoning cases which need immediate attention.
"We are launching the Toxin Toolkit to make information more easily accessible to vets, however an added benefit is that it helps us and our clients to minimise our environmental impact by reducing the need for our printed poisoning guidelines."
To access the Toxin Toolkit, visit: https://www.tvm-uk.com/vet-resource-library/
The updated indications reflect the recognition that Stelfonta may be used in any case where surgery may not be an option:
For the treatment of non-metastatic (WHO staging) mast cell tumours that are either non-resectable or those that are resectable but where surgery is not considered the best option, specifically: cutaneous mast cell tumours (located anywhere on the dog) and subcutaneous mast cell tumours located at or distal to the elbow or the hock.
Tumours must be less than or equal to 8 cm 3 in volume, and must be accessible to intratumoral injection.
Neil Mottram MRCVS, Technical Manager at Virbac said: “Stelfonta offers veterinary surgeons a medical option for the successful elimination of mast cell tumours.
"The extended labelled indication demonstrates the wide variety of cases that can benefit where medical treatment is preferred, such as; tumour factors (location and size) making surgical margins difficult, patient factors (concurrent disease and risk of anaesthesia), clinic factors and the simplification of this medical treatment and owner factors, where there is a preference to avoid surgery."
Stelfonta is administered by injection directly into the tumour mass and Virbac say that generally, dogs do not require sedation or local or general anaesthesia during treatment.
The active ingredient, Tigilanol tiglate, works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
www.virbac.co.uk
Virbac Animal Health has launched a new pet owner information pack to help practices raise awareness of reproductive health issues in dogs and cats.
The pack consists of a leaflet holder with four different leaflets covering unwanted sexual behaviour, castration, prostate disease and misalliance. The holder has a small footprint so will sit nicely in any practice reception area.
Product manager Chris Geddes MRCVS says that the pack will make it easier for vets and VNs to raise the sensitive issue of pet reproductive health with owners. "For example, prostate disease in men is well documented and public knowledge is high, but we believe that few people know that it can affect pets too.
"It is estimated that 80% of male dogs over the age of five suffer from prostate problems, but experts agree that it is underdiagnosed at present. This is possibly due to a combination of a lack of awareness and client unease on discussing reproductive subjects at their vet practice."
To obtain your free pack or for further information, please contact your local territory manager or call Virbac on 01359 243243.
The company says the return to a ‘new normal’ post-lockdown provides a significant opportunity for practices to apply a renewed focus to preventative healthcare, recommending parasiticides as a way to improve animal welfare and generate practice revenue, which is vital for economic recovery.
Caitrina Oakes, Vetoquinol Managing Director UK and Ireland, said: “With many pet owners spending more hours than ever with their pets during lockdown, companion animal parasiticides have never been more important – making Profender and Drontal highly relevant in the current environment.”
She added: “It’s a very challenging time for many veterinary practices as everyone adapts to the post-COVID world. I’m looking forward to seeing how the passion and ambition we bring to our brands helps Profender and Drontal to grow and helps us to better serve the needs of the veterinary community, both now and in the future.”
Up to date information on the brands and their distribution can be found on the Vetoquinol website, www.vetoquinol.co.uk, by calling 01280 814500, or practices can contact their Vetoquinol Territory Manager directly.
Royal Canin has announced the winner of its second annual Weigh In Club initiative: a 32kg 12 year old Beagle called Amber that lost 12.5kg, or 39% of her bodyweight.
The dog lost weight with the help of Veterinary Nurse Gabby Taylor from Wilson Vet Group in Bishop Auckland, and won a year's supply of Royal Canin food along with £500 of gift vouchers for her owner. Gabby also won £500 of vouchers for her efforts, as well as £1000 of equipment vouchers for her practice.
Gabby said: "Amber was referred to my weight clinic and we quickly started her on Royal Canin's Satiety Support diet. Over the course of six months, Amber lost weight healthily and reached her target weight of 19.5kg, making her a much happier dog."
117 dogs took part in the initiative, with the 12 finalists invited to appear in a Royal Canin 2013 'Weigh In Club Winners' calendar.
The competition, which is due to be repeated in 2013, was open to all vet practices which run weight clinics and use Royal Canin 'Obesity Management' and 'Satiety Support' diets as part of weight loss programmes run by Veterinary Nurses.
Ian Williams BVSc MRCVS, Royal Canin's Veterinary Support Manager, said: "With canine and feline obesity on the increase, Veterinary Nurses have an important role to play in educating pet owners and supporting the weight loss process. Choosing the right nutrition for the individual pet is a key part of a successful weight management programme, along with a tailored exercise plan, regular monitoring and commitment from the owner."
For more information about Royal Canin's diets, call the company's veterinary helpline on 0800 717800 or visit www.royalcanin.co.uk
By offering an alternative to face-to-face consultations, VetHelpDirect's online consultation platform provides a means to continue to care for animals while protecting both clients and vet practice staff and still maintaining revenue streams.
The system can be used by clients on most smart phones or tablet devices. Clients can book online or be sent a link by the practice, and payment taken online before the consultation starts.
Transactions on the platform are subject to a 4.8% platform fee and at the end of the 3 month free period, the service costs £20 per month. In addition, to continue using the service, practices need to be registered on the VetHelpDirectory, which costs £38 per month for the first branch and £16 for each additional branch.
For more information, visit: bit.ly/VHD_registration, where you can 'self onboard'. On which note, I will disembark.
SRUC, which is the biggest provider of veterinary nursing, livestock husbandry and animal care training in Scotland, says it will offer a core veterinary programme to address existing shortages in veterinary provision, in areas such as rural veterinary practice, food production, food safety and animal and public health.
The College is first establishing a working group to progress the plans for the school. The group will be chaired by Professor Sir Pete Downes, former Principal and Vice-Chancellor of the University of Dundee.
Sir Pete will be joined by Sheila Voas, Chief Veterinary Officer for Scotland, former NFUS President Nigel Miller, SRUC Board member Jane Craigie, and Dr Kate Richards, who is a non-executive director on the SAC Commercial Board and currently the junior vice president of the RCVS, in line to become President in July.
Professor Caroline Argo, currently Dean of SRUC’s North Faculty, will lead the project for SRUC.
A report from BiGGAR Economics has found that the vet school could add £26 million GVA and 242 jobs to Scotland by 2030.
Professor Wayne Powell, Principal and Chief Executive of SRUC, said: “We are an ambitious institution with a bold vision for the future. This is a ground-breaking model to expand access to educational opportunities and broaden the range of potential students who would not ordinarily be able to attend a vet school. It will also help solve existing skills shortages across Scotland.
“We see a key role of the new vet school in sustaining primary agriculture and hence food and drink productivity, with the welfare of both livestock and companion animals at its heart. The school will produce champions for best-in-class animal welfare in support of these industries, which will help improve productivity, effectiveness, and sustainability.”
“Building on the excellent new facilities we have already announced for Aberdeen and Inverness, there is a lot of work still to be done, but we are ready to seize the opportunity.”
The company says the like-for-like sales increase was at the upper end of its target of between 4% and 8%, and that it continues to see resilience in the veterinary sector, with membership of its Healthy Pet Club preventative healthcare scheme increasing in the year by 19,000 members (an increase of 4.0%) to 489,000.
CVS says its Board decided to enter the Australian marketplace because of its low levels of corporate consolidation, favourable market dynamics and strong similarities with the UK, including highly trained veterinary surgeons, shared language and culture, and the group's experience with UK vets working between Australia and the UK.
Earlier this month, the group signed agreements for the conditional acquisitions of four independent small animal first opinion veterinary practices in Australia: two in Brisbane, one in Queensland and one in Sydney, for an initial consideration of £16.8M.
Two of the acquisitions have now been completed, and the other two are expected to be completed shortly.
The company says it now plans to acquire more Australian practices in major urban conurbations, including Sydney, Melbourne, Brisbane, Perth, Canberra, Newcastle and Adelaide.
Ben Jacklin, Deputy CEO said: "Having worked as a vet in Australia earlier in my career, I know well their high standards of clinical care, and the dedication of highly talented veterinary professionals that work there.
"As a company dedicated to giving the best possible care to animals, I see a fantastic opportunity for us to enter this growing market, with low levels of corporate consolidation, and execute our vision of being the veterinary company people most want to work for.
"I have spent time in Australia over the last 12 months, including meeting some fantastic veterinary practices, and it is clear we have a significant opportunity.
"With the four outstanding practices that are joining us, and a strong pipeline of further acquisition opportunities, I am excited to build a significant CVS business in Australia with the same culture and values that have brought us success in the UK."
A single vial can now be used for 8 days after reconstitution when stored in a fridge at between two and eight degrees celsius.
This, says Virbac, will help maximise the use of each vial, ultimately reducing wastage and providing a cost-effective solution.
Undertaken in practice, industry and academia, submissions are open each year offering the chance to present a Clinical Abstract, presented as a poster or an oral presentation.
Christine Pye won the Medicine Award for her longitudinal study of age, sex and health-related changes in physical biomarkers in pet cats
Alberto Sesana won the Surgery Award for his abstract: "Outcome of lip-to-lid subdermal plexus flaps to reconstruct defects of the lower eyelid in dogs and cats: 46 cases (2005-2022)."
Deborah Komianos won the Practitioner Award for "Reducing use of critically important antibiotics: A clinician-led improvement project across 21 UK small animal veterinary practices."
Rosemary Perkins won the Poster Award for: "Swimming emissions from dogs treated with spot-on fipronil and imidacloprid: assessing the environmental risk."
Lastly but not leastly, Claudia Franzini won the Student Award for: "Does the surgical method for management of Cranial Cruciate Ligament Rupture in dogs affect clinical outcome?"
Submissions for the 2026 Clinical Abstracts will open on 8th September 2025.
https://www.bsavacongress.com
Photo: L-R, Alberto Sesana, Deborah Komianos, Christine Pye, Rosemary Perkins, Claudia Franzini
Dechra Veterinary Products (maker of Cardisure) has launched a new online CPD course which consists of a series of short presentations about treating congestive heart failure in dogs, developed with cardiology consultant Mike Martin.
According to the company, approximately 10% of dogs presented to first opinion practices have heart disease. The majority of cases are suffering with myxomatous mitral valve disease (MMVD) or, less commonly, dilated cardiomyopathy (DCM).
Mike said: "This is a series of short presentations with audio, that covers the common challenges, issues and questions that we all encounter in clinical practice. Aimed squarely at the very busy practitioner, this 'piece by piece' course will help you differentiate between cardiac and respiratory cases, update you on the current ACVIM guidelines on the treatment of heart failure in dogs and how best to monitor your patient in the short to long term. It's been a fun series to put together with the help of Dechra – enjoy."
Craig Sankey, Business Manager for Cardiology at Dechra said: "This series of bite-sized videos highlight the importance of diagnosing, treating and monitoring congestive heart failure in dogs in an interactive e-learning environment, topped with quizzes and drag and drops to test ones knowledge.
"Furthermore, the beauty of this format means Veterinary Professionals can dip in and out of each section depending on the area they need to build their expertise, without the pressure of completing the whole course all at once’.
The course equates to one hour CPD and can be found on the Dechra Academy: https://academy.dechra.com/learn/course/external/view/elearning/718/cardiology-piece-by-piece
More information about Cardisure can be found at www.dechra.co.uk/Cardisure
This year, in collaboration with Your Cat, the charity is looking for entries which showcase the cat-human bond with a brand new theme of ‘Cat-Human Relationships’.
The judges want to see a range of relationships in a variety of situations, locations and ages. For instance, entries can include but are not limited to: pet cats with their owners in the home, street cats with the public and cats with those who work with them eg, veterinary professionals with their patients and homing centre workers with the cats in their care.
Since its launch in 2013, the competition has collectively attracted over 15,000 entries from all over the world.
Eve Davies, who runs the competition, said: "Whilst we tend to think of our relationship with cats as that of pet and owner, cats and humans can have a huge variety of unique connections with each other and we would love to see this reflected in the entries.
"This year’s theme is quite different to previous topics – for example kittens or sleeping cats – but it has the potential to be much more rewarding. As well as receiving exceptional photos over the years, we have been sent some incredibly moving stories to accompany them and we are hoping that this year will be even better still."
Twelve winning images will be selected by the iCatCare and Your Cat Magazine judges to feature in the charity’s 2020 calendar (and other materials) which will be sold to raise funds for the charity’s work, with one crowned the overall winner and gracing the front cover.
All twelve winners will each receive a certificate, copies of the calendar and a selection of iCatCare merchandise. The overall winner will also receive £500 in prize money.
To find out more and to enter, visit: www.icatcare.org/photography-competition. The competition closes at 10 am (BST) on 1 July 2019.
For this study, researchers in Argentina, Italy, Austria and Chile, set out to evaluate the efficacy of and adverse events from the administration of ACEIs to treat preclinical MMVD in dogs, via a systematic review of published evidence conducted according to the Cochrane Handbook for Systematic Reviews of Interventions.
Certainty of evidence was assessed using the GRADE (https://gradepro.org) approach.
The main finding in relation to dogs with preclinical MMVD and cardiomegaly was backed by a high certainty of evidence. The certainty of evidence in relation to the efficacy of ACEI administration in dogs without cardiomegaly was low.
Dr Pablo Donati, corresponding author for the paper, said: “In recent times, multiple clinical trials have provided fundamental information to veterinary cardiology.
"In the era of evidence-based medicine, systematic reviews and meta-analyses have emerged as a fundamental tool for clinical decision-making by gathering, appraising and summarizing the best available evidence.
"It is the hope of the authors that this systematic review and meta-analysis helps in the decision-making process for the treatment of preclinical myxomatous mitral disease with angiotensin-converting enzyme inhibitors in dogs.”
Nicola Di Girolamo, Editor of JSAP, added: “In line with other leading journals, the JSAP is prioritizing the publication of methodologically sound systematic reviews such as this one.
"However, our readers should be aware that the findings of systematic reviews should always be considered in light of their internal validity, i.e. the quality of the included studies, and their external validity, i.e. the generalizability of the included studied to the individual patient.”
Reference
Donati, P., Tarducci, A., Zanatta, R., Verdier, N., Belerenian, G., Cordero, I., Villalta, C., Franco, J. and Tarragona, L. (2022), Angiotensin-converting enzyme inhibitors in preclinical myxomatous mitral valve disease in dogs: systematic review and meta-analysis. J Small Anim Pract. https://doi.org/10.1111/jsap.13461
Cystease® S, CEVA Animal Health's urinary tract support product for cats, is now available in a new 100 tablet pack size for greater convenience to the practice.
CEVA`s small animal veterinary advisor Fraser Broadfoot said: "Previously Cystease® S was only available in 300 tablet packs. The new 100 tablet pack size makes the product easier to store in the practice and easier to dispense to clients."
To help vets gain easy access to information on Feline Lower Urinary Tract Disease (FLUTD), CEVA Animal Health have also produced a highly informative technical review on the subject. Produced in conjunction with Professor Danielle Gunn-Moore, head of the feline clinic at the University of Edinburgh, the eight-page, colour brochure contains practical information on the clinical signs, diagnosis and treatment of FLUTD and also includes behavioural advice on reducing stress in cats, which can be a major cause of FLUTD.
To receive a free copy of CEVA's FLUTD technical review and for further information on Cystease® S, please contact Fraser Broadfoot MRCVS on 01494 781510, CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.